Clinuvel Pharmaceuticals (CUVL) vs Decent (DXST)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Clinuvel Pharmaceuticals is the larger company by market cap ($280.7 million vs $4.6 million), about 60.8 times the size. Clinuvel Pharmaceuticals pays a dividend yielding 0.90%, while Decent does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CUVL | DXST |
|---|---|---|
| Share price | $5.56 | $1.93 |
| Market cap | $280.71M | $4.62M |
| 1-day change | -0.71% | +6.06% |
| YTD return | -33.96% | — |
| 1-year return | -31.62% | — |
| 5-year return | -81.60% | — |
| P/E ratio (TTM) | 12.36 | — |
| EPS (TTM) | $0.45 | $-0.34 |
| Dividend yield | 0.90% | 0.00% |
| Annual dividend | $0.05 | $0.00 |
| 52-week high | $8.92 | $62.00 |
| 52-week low | $5.53 | $1.50 |
| Distance from 52-week high | -37.67% | -96.89% |
| Average volume | 13.01K | 1.63M |
| Shares outstanding | 50.49M | 1.79M |
| Employees | — | 16 |
| Sector | Miscellaneous | Industrials |
| Industry | Miscellaneous | Miscellaneous |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Clinuvel Pharmaceuticals is about 60.8 times larger than Decent by market value ($280.71M vs $4.62M).
- The two companies sit in different sectors: Clinuvel Pharmaceuticals in Miscellaneous and Decent in Industrials.
About Clinuvel Pharmaceuticals
CUVL stock →Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and delivering therapies for patients with genetic, metabolic, and dermatological disorders in Australia, Ireland, the United States, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP).
Miscellaneous · Miscellaneous
About Decent
DXST stock →Decent Holding Inc., through its subsidiaries, provides industrial wastewater treatment services in the People's Republic of China. The company offers ecological river restoration and river ecosystem management services.
Industrials · Miscellaneous · 16 employees
CUVL vs DXST FAQ
Which is bigger, Clinuvel Pharmaceuticals or Decent?
Clinuvel Pharmaceuticals (CUVL) is larger, with a market capitalization of $280.71M compared with $4.62M for Decent (DXST).
Which pays a higher dividend, Clinuvel Pharmaceuticals or Decent?
Clinuvel Pharmaceuticals pays a dividend yielding 0.90%, while Decent does not currently pay a regular dividend.
Are Clinuvel Pharmaceuticals and Decent in the same industry?
Yes. Both are classified in the Miscellaneous industry within the Miscellaneous sector.